N-Arylrolipram derivatives as potent and selective PDE4 inhibitors

Bioorganic & Medicinal Chemistry Letters
1998.0

Abstract

Derivatization of rolipram led to the identification of 3-[4-(3-cyclopentyloxy-4-methoxyphenyl)-2-oxo-pyrrolidin-1-yl]-5-( 3- methoxybenzyloxy)-benzoic acid N',N'-dimethylhydrazide (4), a potent and selective inhibitor of PDE4, which inhibits the activation of human leukocytes with pIC50 values in the range of 7.3-7.8, and blocks antigen induced eosinophilia in Brown Norway rats at a dose of 1 mg/kg (i.t.).

Knowledge Graph

Similar Paper

N-Arylrolipram derivatives as potent and selective PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 1998.0
Synthesis and structure–activity relationships of 4-oxo-1-phenyl-3,4,6,7-tetrahydro-[1,4]diazepino[6,7,1- hi ]indoles: novel PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2000.0
8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma
Bioorganic & Medicinal Chemistry Letters 2002.0
Synthesis and biological activities of 1-pyridylisoquinoline and 1-pyridyldihydroisoquinoline derivatives as PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2003.0
Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogs
Journal of Medicinal Chemistry 1994.0
The selective inhibition of phosphodiesterase IV by benzopyran derivatives of rolipram
Bioorganic & Medicinal Chemistry Letters 1993.0
Phthalazine PDE4 inhibitors. Part 2: The synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivatives
Bioorganic & Medicinal Chemistry Letters 2001.0
Design, synthesis and in vitro PDE4 inhibition activity of certain quinazolinone derivatives for treatment of asthma
Medicinal Chemistry Research 2012.0
Aryl sulfonamides as selective PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 1998.0
Phthalazine PDE4 inhibitors. Part 3: The synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptor
Bioorganic & Medicinal Chemistry Letters 2002.0